Stress and fatigue reduction
Clinical trials consistently show rhodiola reduces mental fatigue, burnout symptoms, and stress-related exhaustion. Particularly effective for stress-induced fatigue in professionals and students.
Cognitive performance
Improves attention, processing speed, and associative thinking during stressful periods. A 20-day trial in students during exam periods showed significant improvement in mental performance and well-being.
Physical endurance
Enhances aerobic exercise capacity and reduces exercise-induced muscle damage. Meta-analyses show modest but consistent improvements in VO2 max and time-to-exhaustion in trained athletes.
Mood and depression support
Several RCTs show rhodiola extract comparable to sertraline for mild-to-moderate depression with significantly fewer side effects, mediated through monoamine oxidase inhibition and serotonin modulation.
HPA axis modulation
Rosavins and salidroside modulate the hypothalamic-pituitary-adrenal (HPA) axis response to stress, reducing cortisol secretion during acute stressors and supporting faster cortisol recovery post-stress.
Monoamine oxidase inhibition
Rhodiola constituents inhibit monoamine oxidase A and B enzymes, reducing breakdown of serotonin, dopamine, and norepinephrine in the brain, contributing to antidepressant and anxiolytic effects.
Mitochondrial energy production
Salidroside activates AMPK and supports mitochondrial biogenesis, increasing cellular ATP production efficiency. This explains the anti-fatigue and endurance-enhancing effects observed in clinical studies.
RCT of 400 mg/day rhodiola extract (SHR-5) vs. placebo in 118 patients with stress-related burnout for 12 weeks.
118 adults with burnout syndrome. 12-week intervention.
Significant improvements in burnout, emotional exhaustion, depersonalization, and cognitive function vs. placebo. Well-tolerated; no serious adverse events.
RCT comparing rhodiola extract (340 mg/day), sertraline (50 mg/day), and placebo in 57 adults with depression.
57 adults with mild-to-moderate depression. 12-week intervention.
Both rhodiola and sertraline reduced depression scores vs. placebo, with no significant difference between treatments. Sertraline had significantly more side effects.